Dignitana AB Publishes Q2 2024 Interim Report
Advancing forward with clear vision Financial highlights Q2 2024 · Net Sales amounted to 21.8 MSEK (21.1), an increase of 4 percent over the same quarter in 2023. · Operating Result amounted to -11.0 MSEK (-4.7). · Net Result after financial items amounted to -11.5 MSEK (-4.7). · EBITDA for the second quarter were negative at -7.0 MSEK (-0.9). · Earnings per share were -0.14 SEK (-0.07). · Cash Balance amounted to 7.0 MSEK (5.4). · Average Daily Treatment Revenue (ADTR)* was 223 TSEK (241) in the quarter. Business highlights during the period · Dignitana